Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention.

Pencina KM, Thanassoulis G, Wilkins JT, Vasan RS, Navar AM, Peterson ED, Pencina MJ, Sniderman AD.

J Am Coll Cardiol. 2019 Jul 9;74(1):70-79. doi: 10.1016/j.jacc.2019.04.047.

PMID:
31272554
2.

Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.

Perrot N, Thériault S, Dina C, Chen HY, Boekholdt SM, Rigade S, Després AA, Poulin A, Capoulade R, Le Tourneau T, Messika-Zeitoun D, Trottier M, Tessier M, Guimond J, Nadeau M, Engert JC, Khaw KT, Wareham NJ, Dweck MR, Mathieu P, Pibarot P, Schott JJ, Thanassoulis G, Clavel MA, Bossé Y, Arsenault BJ.

JAMA Cardiol. 2019 May 29. doi: 10.1001/jamacardio.2019.1581. [Epub ahead of print]

PMID:
31141105
3.

LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia.

Paquette M, Bernard S, Thanassoulis G, Baass A.

J Clin Lipidol. 2019 Apr 23. pii: S1933-2874(19)30082-0. doi: 10.1016/j.jacl.2019.04.006. [Epub ahead of print]

PMID:
31103339
4.

ApoB.

Sniderman AD, Pencina M, Thanassoulis G.

Circ Res. 2019 May 10;124(10):1425-1427. doi: 10.1161/CIRCRESAHA.119.315019. No abstract available.

PMID:
31070997
5.

Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.

Bortnick AE, Xu S, Kim RS, Kestenbaum B, Ix JH, Jenny NS, de Boer IH, Michos ED, Thanassoulis G, Siscovick DS, Budoff MJ, Kizer JR.

Atherosclerosis. 2019 Jun;285:79-86. doi: 10.1016/j.atherosclerosis.2019.04.215. Epub 2019 Apr 13.

PMID:
31048102
6.

The 2018 ACC/AHA Lipid Guidelines: A Little More or Less Canadian?

Thanassoulis G, Gregoire J, Pearson GJ.

Can J Cardiol. 2019 May;35(5):558-563. doi: 10.1016/j.cjca.2019.03.003. Epub 2019 Mar 19. No abstract available.

PMID:
31030858
7.

Using Genetics to Plan Future Randomized Trials of Lipoprotein(a) Lowering-How Much Reduction, for How Long, and in Whom?

Thanassoulis G.

JAMA Cardiol. 2019 Apr 24. doi: 10.1001/jamacardio.2019.1107. [Epub ahead of print] No abstract available.

PMID:
31017615
8.

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.

Patel RS, Schmidt AF, Tragante V, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Dubé MP, Allayee H, Almgren P, Alver M, Baranova EV, Behlouli H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dufresne L, Eriksson N, Foco L, Gijsberts CM, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Fitzpatrick N, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Bogaty P, de Borst GJ, Brenner H, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Johnson JA, de Jong PA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Pepinski W, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Scholz M, Siegbahn A, Sinisalo J, Smith JG, Spertus JA, Stewart AFR, Szczeklik W, Szpakowicz A, Ten Berg JM, Thanassoulis G, Thiery J, van der Graaf Y, Visseren FLJ, Waltenberger J; CARDIoGRAMPlusC4D Consortium, Van der Harst P, Tardif JC, Sattar N, Lang CC, Pare G, Brophy JM, Anderson JL, März W, Wallentin L, Cameron VA, Horne BD, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002471. doi: 10.1161/CIRCGEN.119.002471. Epub 2019 Mar 21.

PMID:
30897348
9.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease.

Patel RS, Tragante V, Schmidt AF, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Allayee H, Almgren P, Alver M, Baranova EV, Behloui H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dubé MP, Dufresne L, Eriksson N, Foco L, Scholz M, Gijsberts CM, Glinge C, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kotti S, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, Van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Al Ali L, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Engstrøm T, Fitzpatrick N, Fox K, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton-Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Boersma EH, Bogaty P, Bots ML, Brenner H, Brugts JJ, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, Danchin N, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Grobbee DE, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Jabbari R, Johnson JA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Niemcunowicz-Janica A, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Siegbahn A, Simon T, Sinisalo J, Smith JG, Spertus JA, Stender S, Stewart AFR, Szczeklik W, Szpakowicz A, Tardif JC, Ten Berg JM, Tfelt-Hansen J, Thanassoulis G, Thiery J, Torp-Pedersen C, van der Graaf Y, Visseren FLJ, Waltenberger J, Weeke PE, Van der Harst P, Lang CC, Sattar N, Cameron VA, Anderson JL, Brophy JM, Pare G, Horne BD, März W, Wallentin L, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002470. doi: 10.1161/CIRCGEN.119.002470. Epub 2019 Mar 21.

PMID:
30896328
10.

Screening for High Lipoprotein(a).

Thanassoulis G.

Circulation. 2019 Mar 19;139(12):1493-1496. doi: 10.1161/CIRCULATIONAHA.119.038989. No abstract available.

PMID:
30883219
11.

Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis.

Steffen BT, Thanassoulis G, Duprez D, Stein JH, Karger AB, Tattersall MC, Kaufman JD, Guan W, Tsai MY.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):523-529. doi: 10.1161/ATVBAHA.118.312267.

PMID:
30727753
12.

Risk factors for valvular calcification.

Chen HY, Engert JC, Thanassoulis G.

Curr Opin Endocrinol Diabetes Obes. 2019 Apr;26(2):96-102. doi: 10.1097/MED.0000000000000471.

PMID:
30694830
13.

A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention.

Thanassoulis G, Sniderman AD, Pencina MJ.

JAMA Cardiol. 2018 Nov 1;3(11):1090-1095. doi: 10.1001/jamacardio.2018.3476.

PMID:
30422172
14.

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated.

Sniderman AD, Thanassoulis G, Wilkins JT, Furberg CD, Pencina M.

J Am Heart Assoc. 2018 Oct 2;7(19):e010049. doi: 10.1161/JAHA.118.010049. No abstract available.

15.

The spectrum of type III hyperlipoproteinemia.

Sniderman AD, de Graaf J, Thanassoulis G, Tremblay AJ, Martin SS, Couture P.

J Clin Lipidol. 2018 Nov - Dec;12(6):1383-1389. doi: 10.1016/j.jacl.2018.09.006. Epub 2018 Sep 14.

PMID:
30318453
16.

Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification.

Yu B, Hafiane A, Thanassoulis G, Ott L, Filwood N, Cerruti M, Gourgas O, Shum-Tim D, Al Kindi H, de Varennes B, Alsheikh-Ali A, Genest J, Schwertani A.

JACC Basic Transl Sci. 2017 Aug 28;2(4):358-371. doi: 10.1016/j.jacbts.2017.03.015. eCollection 2017 Aug.

17.

Precision Medicine for Prosthetic Valve Deterioration: A Glimpse Into the Future?

Thanassoulis G.

J Am Coll Cardiol. 2018 Jul 17;72(3):252-254. doi: 10.1016/j.jacc.2018.04.065. Epub 2018 Jul 9. No abstract available.

PMID:
30012317
18.

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding.

Sniderman AD, Couture P, Martin SS, DeGraaf J, Lawler PR, Cromwell WC, Wilkins JT, Thanassoulis G.

J Lipid Res. 2018 Jul;59(7):1266-1275. doi: 10.1194/jlr.R082271. Epub 2018 May 16.

19.

Selection Bias in Cardiology Research: Another Thing to Worry About (and How to Correct for It).

Labos C, Thanassoulis G.

Can J Cardiol. 2018 Jun;34(6):705-708. doi: 10.1016/j.cjca.2018.03.010. Epub 2018 Mar 23. No abstract available.

PMID:
29731184
20.

Response by Labos et al to Letter Regarding Article, "Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression".

Labos C, Brophy JM, Smith GD, Sniderman AD, Thanassoulis G.

Arterioscler Thromb Vasc Biol. 2018 May;38(5):e87-e88. doi: 10.1161/ATVBAHA.118.310907. No abstract available.

PMID:
29695535
21.

Observational and Genetic Associations of Resting Heart Rate With Aortic Valve Calcium.

Whelton SP, Mauer AC, Pencina KM, Massaro JM, D'Agostino RB, Fox CS, Hoffmann U, Michos ED, Peloso GM, Dufresne L, Engert JC, Kathiresan S, Budoff M, Post WS, Thanassoulis G, O'Donnell CJ.

Am J Cardiol. 2018 May 15;121(10):1246-1252. doi: 10.1016/j.amjcard.2018.01.048. Epub 2018 Feb 13.

PMID:
29656781
22.

Pathological significance of lipoprotein(a) in aortic valve stenosis.

Yu B, Khan K, Hamid Q, Mardini A, Siddique A, Aguilar-Gonzalez LP, Makhoul G, Alaws H, Genest J, Thanassoulis G, Cecere R, Schwertani A.

Atherosclerosis. 2018 May;272:168-174. doi: 10.1016/j.atherosclerosis.2018.03.025. Epub 2018 Mar 15.

PMID:
29614432
23.

Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update.

Labos C, Thanassoulis G.

Curr Cardiol Rep. 2018 Mar 24;20(5):36. doi: 10.1007/s11886-018-0980-0. Review.

PMID:
29574623
24.

Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation.

Zhan Y, Joza J, Al Rawahi M, Barbosa RS, Samuel M, Bernier M, Huynh T, Thanassoulis G, Essebag V.

Can J Cardiol. 2018 Mar;34(3):252-261. doi: 10.1016/j.cjca.2017.12.008. Epub 2017 Dec 15. Review.

PMID:
29395705
25.

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.

Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, Santos RD, Thanassoulis G, Witztum JL, Danthi S, Olive M, Liu L.

J Am Coll Cardiol. 2018 Jan 16;71(2):177-192. doi: 10.1016/j.jacc.2017.11.014. Review.

26.

Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records.

Chen HY, Dufresne L, Burr H, Ambikkumar A, Yasui N, Luk K, Ranatunga DK, Whitmer RA, Lathrop M, Engert JC, Thanassoulis G.

JAMA Cardiol. 2018 Jan 1;3(1):18-23. doi: 10.1001/jamacardio.2017.4266.

27.

Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression-Brief Report.

Labos C, Brophy JM, Smith GD, Sniderman AD, Thanassoulis G.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):262-265. doi: 10.1161/ATVBAHA.117.310052. Epub 2017 Nov 9.

PMID:
29122815
28.

Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.

Burstein B, Altobelli KK, Williams K, Cannon CP, Pencina MJ, Sniderman AD, Thanassoulis G.

Circulation. 2017 Nov 7;136(19):1860-1862. doi: 10.1161/CIRCULATIONAHA.117.029102. No abstract available.

PMID:
29109198
29.

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.

Durand M, Chartrand-Lefebvre C, Baril JG, Trottier S, Trottier B, Harris M, Walmsley S, Conway B, Wong A, Routy JP, Kovacs C, MacPherson PA, Monteith KM, Mansour S, Thanassoulis G, Abrahamowicz M, Zhu Z, Tsoukas C, Ancuta P, Bernard N, Tremblay CL; investigators of the Canadian HIV and Aging Cohort Study.

BMC Infect Dis. 2017 Sep 11;17(1):611. doi: 10.1186/s12879-017-2692-2.

30.

The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines.

Thanassoulis G, Pencina MJ, Sniderman AD.

JAMA Cardiol. 2017 Nov 1;2(11):1175-1176. doi: 10.1001/jamacardio.2017.2543. No abstract available.

PMID:
28793137
31.

Fractional Flow Reserve–Guided Multivessel Angioplasty in Myocardial Infarction.

Bibas L, Thanassoulis G.

N Engl J Med. 2017 Jul 27;377(4):396-7. doi: 10.1056/NEJMc1706275. No abstract available.

PMID:
28748687
32.

Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification.

Afshar M, Luk K, Do R, Dufresne L, Owens DS, Harris TB, Peloso GM, Kerr KF, Wong Q, Smith AV, Budoff MJ, Rotter JI, Cupples LA, Rich SS, Engert JC, Gudnason V, O'Donnell CJ, Post WS, Thanassoulis G; CHARGE Extracoronary Calcium Working Group.

J Am Coll Cardiol. 2017 Jun 20;69(24):2941-2948. doi: 10.1016/j.jacc.2017.04.051.

33.

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.

Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, Blankenberg S, Waldeyer C, Sinning C, Schnabel RB, Lackner KJ, Vlachopoulou E, Nygård O, Svingen GFT, Pedersen ER, Tell GS, Sinisalo J, Nieminen MS, Laaksonen R, Trompet S, Smit RAJ, Sattar N, Jukema JW, Groesdonk HV, Delgado G, Stojakovic T, Pilbrow AP, Cameron VA, Richards AM, Doughty RN, Gong Y, Cooper-DeHoff R, Johnson J, Scholz M, Beutner F, Thiery J, Smith JG, Vilmundarson RO, McPherson R, Stewart AFR, Cresci S, Lenzini PA, Spertus JA, Olivieri O, Girelli D, Martinelli NI, Leiherer A, Saely CH, Drexel H, Mündlein A, Braund PS, Nelson CP, Samani NJ, Kofink D, Hoefer IE, Pasterkamp G, Quyyumi AA, Ko YA, Hartiala JA, Allayee H, Tang WHW, Hazen SL, Eriksson N, Held C, Hagström E, Wallentin L, Åkerblom A, Siegbahn A, Karp I, Labos C, Pilote L, Engert JC, Brophy JM, Thanassoulis G, Bogaty P, Szczeklik W, Kaczor M, Sanak M, Virani SS, Ballantyne CM, Lee VV, Boerwinkle E, Holmes MV, Horne BD, Hingorani A, Asselbergs FW, Patel RS; GENIUS-CHD consortium, Krämer BK, Scharnagl H, Fliser D, März W, Speer T.

Lancet Diabetes Endocrinol. 2017 Jul;5(7):534-543. doi: 10.1016/S2213-8587(17)30096-7. Epub 2017 May 26.

34.

Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyte.

Sniderman AD, Kiss RS, Reid T, Thanassoulis G, Watts GF.

Clin Sci (Lond). 2017 May 1;131(9):791-797. doi: 10.1042/CS20160872.

PMID:
28424373
35.

Recovery in Patients With Dilated Cardiomyopathy With Loss-of-Function Mutations in the Titin Gene.

Luk K, Bakhsh A, Giannetti N, Elstein E, Lathrop M, Thanassoulis G, Engert JC.

JAMA Cardiol. 2017 Jun 1;2(6):700-702. doi: 10.1001/jamacardio.2017.0763. No abstract available.

36.

Case of Reversible Complete Heart Block.

De l'Étoile-Morel S, Feteih A, Hogan CA, Vinh DC, Thanassoulis G.

Am J Med. 2017 Aug;130(8):e335-e336. doi: 10.1016/j.amjmed.2017.02.022. Epub 2017 Mar 24. No abstract available.

PMID:
28344143
37.

A Replicated, Genome-Wide Significant Association of Aortic Stenosis With a Genetic Variant for Lipoprotein(a): Meta-Analysis of Published and Novel Data.

Cairns BJ, Coffey S, Travis RC, Prendergast B, Green J, Engert JC, Lathrop M, Thanassoulis G, Clarke R.

Circulation. 2017 Mar 21;135(12):1181-1183. doi: 10.1161/CIRCULATIONAHA.116.026103. No abstract available.

PMID:
28320808
38.

Lipoprotein(a): new insights from modern genomics.

Afshar M, Thanassoulis G.

Curr Opin Lipidol. 2017 Apr;28(2):170-176. doi: 10.1097/MOL.0000000000000392. Review.

PMID:
28059953
39.

Variants in ANGPTL4 and the Risk of Coronary Artery Disease.

Sniderman AD, Thanassoulis G.

N Engl J Med. 2016 Dec 8;375(23):2304. doi: 10.1056/NEJMc1607380. No abstract available.

PMID:
27959692
40.

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.

Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GB, McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R.

Can J Cardiol. 2016 Nov;32(11):1263-1282. doi: 10.1016/j.cjca.2016.07.510. Epub 2016 Jul 25. Review.

PMID:
27712954
41.

Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report.

Afshar M, Kamstrup PR, Williams K, Sniderman AD, Nordestgaard BG, Thanassoulis G.

Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2421-2423. Epub 2016 Oct 20.

PMID:
27765771
42.

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.

Sniderman AD, Islam S, McQueen M, Pencina M, Furberg CD, Thanassoulis G, Yusuf S.

J Am Heart Assoc. 2016 Oct 13;5(10). pii: e003665.

43.

Sex Differences in Clinical Outcomes After Premature Acute Coronary Syndrome.

Pelletier R, Choi J, Winters N, Eisenberg MJ, Bacon SL, Cox J, Daskalopoulou SS, Lavoie KL, Karp I, Shimony A, So D, Thanassoulis G, Pilote L; GENESIS-PRAXY Investigators.

Can J Cardiol. 2016 Dec;32(12):1447-1453. doi: 10.1016/j.cjca.2016.05.018. Epub 2016 Sep 26.

PMID:
27683172
44.

An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB.

Sniderman AD, Toth PP, Thanassoulis G, Furberg CD.

J Clin Lipidol. 2016 Sep-Oct;10(5):1248-58. doi: 10.1016/j.jacl.2016.07.008. Epub 2016 Aug 2.

PMID:
27678443
45.

Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events.

Sniderman AD, Thanassoulis G, Williams K, Pencina M.

JAMA Cardiol. 2016 Jul 1;1(4):492-4. doi: 10.1001/jamacardio.2016.0991. No abstract available.

PMID:
27438330
46.

Genetic loci associated with ideal cardiovascular health: A meta-analysis of genome-wide association studies.

Allen NB, Lloyd-Jones D, Hwang SJ, Rasmussen-Torvik L, Fornage M, Morrison AC, Baldridge AS, Boerwinkle E, Levy D, Cupples LA, Fox CS, Thanassoulis G, Dufresne L, Daviglus M, Johnson AD, Reis J, Rotter J, Palmas W, Allison M, Pankow JS, O'Donnell CJ.

Am Heart J. 2016 May;175:112-20. doi: 10.1016/j.ahj.2015.12.022. Epub 2016 Jan 23.

47.

Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).

Afshar M, Pilote L, Dufresne L, Engert JC, Thanassoulis G.

J Am Heart Assoc. 2016 Apr 23;5(4). pii: e003012. doi: 10.1161/JAHA.115.003012.

48.

Association Between Family History, a Genetic Risk Score, and Severity of Coronary Artery Disease in Patients With Premature Acute Coronary Syndromes.

Hindieh W, Pilote L, Cheema A, Al-Lawati H, Labos C, Dufresne L, Engert JC, Thanassoulis G; PRAXY Investigators*.

Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1286-92. doi: 10.1161/ATVBAHA.115.306944. Epub 2016 Apr 21.

PMID:
27102964
49.

Correction: Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.

Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Goltzman D, Leong A, Greenwood CM, Thanassoulis G, Richards JB.

PLoS Med. 2016 Mar 2;13(3):e1001981. doi: 10.1371/journal.pmed.1001981. eCollection 2016 Mar. No abstract available.

50.

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.

Thanassoulis G, Williams K, Altobelli KK, Pencina MJ, Cannon CP, Sniderman AD.

Circulation. 2016 Apr 19;133(16):1574-81. doi: 10.1161/CIRCULATIONAHA.115.018383. Epub 2016 Mar 4.

PMID:
26945047

Supplemental Content

Loading ...
Support Center